| Full Name | Eyecare Specialties Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 620 Main St, Adams, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518989250 | NPI | - | NPPES |
| 0553580001 | Other | NE | DMERC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eyecare Specialties Pc 7930 O St, Lincoln, NE 68510 Ph: (402) 420-2020 | Eyecare Specialties Pc 620 Main St, Adams, NE 68301 Ph: (402) 420-2020 |
News Archive
A billion people living in underdeveloped areas around the world are infected with parasitic helminthes, worms that survive by residing in and feeding on their hosts. These infestations can cause chronic intestinal (and occasionally systemic) illnesses leading to long-term disability. Irah King and Markus Mohrs, biomedical researchers at the Trudeau Institute, are investigating illnesses caused by these gut-dwelling worms in an effort to decipher how immune cells send and receive signals that determine the specific immune response to mount.
The damaging effects of toxic proteins created in one inherited form of amyotrophic lateral sclerosis (ALS) are mediated by a protein called SPOP, according to a study published in the Proceedings of the National Academy of the Sciences.
Southern Home Medical Equipment, Inc., a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, has selected Scott & Company, a Public Company Accounting Oversight Board approved accounting firm in Columbia, SC, to audit the Company's financials for the past two years and provide additional accounting services to the Company.
What if an experimental treatment for an aggressive breast cancer had the potential to save women's lives, but nobody could use it because there was no money to develop and test it? With funding sources for research and development more scarce than in the past, it is not an unusual situation. It's a problem that Sourav Sinha, a Master's degree candidate at Rutgers' Graduate School of Biomedical Sciences, is working to tackle head-on.
uniQure announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion that recommends marketing authorization of Glybera (alipogene tiparvovec) as a treatment for lipoprotein lipase deficiency (LPLD) under exceptional circumstances.
› Verified 5 days ago